MS
chronic inflammatory autoimmune disorder
- loss of the myelin sheath and axons which slows transmission
What cells are affected with MS
white and gray matter of the brain and spinal cord
Neuronal char of MS
inflammation, demyelination, scar dev (Gliosis)
cause of MS
unknown
- genetic predis, autoimm, enviro
known risks for MS
20-40Y, women, moderately cool climate (N. US), Caucasian, fam hx
possible risk fx for MS
smoking, vit D def. obese, infx (Epstein-Barr)
How does MS affect men?
Get worse and more prog sx
MS patho
Neuronal effects of MS (early vs late)
Dec nerve fxn and transmission can cause eventual damage to the axons
- early–fiber not affected, impulse still transmitted, weakness
- late–axon destroyed, impulse blocked, perm loss of fxn
benign MS
no prog loss of fxn and very few exac that are weak
relapsing-remitting MS
Primary progressive MS
steady prog w/o remissions
Secondary progressive MS
initial relapse and remission then progressive decline w/o remissions
Progressive relapsing MS
Gradual progressive decline w/o many remissions
CM of MS
tingling, numbness, paresthesia in face, trunk, and legs, weakness and loss of fxn, vision loss, impaired gait, incontinence, sz, cog fog, depression, fatigue, pain (acute/chronic, burn/stab), bowel/blad (esp constipation), sexual probs, muscle stiffness/spasm, vertigo and falls
Goals of MS pharm
Improve fxn, limit lesions, dec exac
- modify disease process
tx of acute MS relapse
Drugs to tx MS symptoms
Interferon beta-1a/b class and MOA
Interferon beta-1a/b SE and NC
Glatiramer acetate MOA
Inc prod anti-inflam T cells that cross BBB and supp inflam
Glatiramer acetate SE and NC
fingolimod
Retain lymphocytes in lymph nodes, prevent from migrating to BBB–dec inflam
- for RRMS
- oral
Dimethyl fumarate